Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
358 Leser
Artikel bewerten:
(0)

triniti Skin Treatment to be Featured in Keeping Up with The Kardashians Episode / Kris Jenner receives non-surgical treatment by Syneron

IRVINE, Calif., May 11 /PRNewswire-FirstCall/ -- Kris Jenner, entrepreneur, talent manager, socialite, celebrity and co-star of the E! show Keeping up with the Kardashians, will receive the triniti(TM) skin treatment (http://www.trinitiskin.com/), a treatment that dramatically reduces signs of aging, during the May 17 episode airing at 10/9c.

The triniti skin treatment is a 3-in-1 non-surgical procedure for skin tightening with ReFirme, color correction with FotoFacial RF and deep wrinkle treatment with Syneron's Matrix series.

In this episode, Kris and her husband, former Olympian Bruce Jenner, debate a surgical or non-surgical makeover. Kris opts not to get plastic surgery and visits Dr. John Shieh of RejuvaYou Medical Spas in South Pasadena, California, to experience the latest in skin rejuvenation treatments.

"Many of my patients, especially in this economy, are opting out of going under the knife and instead choose non-surgical alternatives like laser treatments," said Dr. Shieh. "Women don't want the tight and plumped, overdone look and are using laser-based treatments like triniti skin treatment to achieve and maintain their desired appearance without the downtime and/or complications associated with surgical procedures."

With three treatments, each spaced four weeks apart, the triniti skin treatment, developed by Syneron(TM) Medical Ltd. , encourages collagen production and new skin cell growth.

To find a triniti skin treatment provider near you or for more information, please visit http://www.trinitiskin.com/. Catch new episodes of Keeping up with the Kardashians Sundays at 10/9c only on E!.

About Syneron

Syneron Medical Ltd. manufactures and distributes medical aesthetic devices that are powered by the proprietary, patented elos(TM) combined-energy technology of bi-polar radio frequency and light. The Company's innovative elos technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications including hair removal, wrinkle reduction, rejuvenating the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, cellulite, circumferential reduction and the treatment of acne, leg veins and laser-assisted lipolysis. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. is located in Israel. Syneron has offices and distributors throughout the world, including North American headquarters in Irvine, California, and Asia-Pacific headquarters in Hong Kong, which provide sales, service and support. Additional information can be found at http://www.syneron.com/.

Syneron, the Syneron logo, triniti skin, ReFirme, Matrix IR, Matrix RF, FotoFacial RF and elos are trademarks of Syneron Medical Ltd. and may be registered in certain jurisdictions. Elos (Electro-Optical Synergy) is a proprietary technology of Syneron Medical. All other names are the property of their respective owners.

Syneron Medical Ltd.

CONTACT: Angela Leon, Airfoil PR for Syneron, +1-248-304-1445,
leon@airfoilpr.com

Web Site: http://www.syneron.com/

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2009 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.